Yunhao ZHAI, PhD student in Bernard and Marie MALISSEN's laboratory at the CIML, is the winner of an EFIS-EJI travel grant to attend the International Immunology Meeting (IUIS 2019). He is one of the 10 candidates to obtain this scholarship awarded to young…
Toby LAWRENCE's groups from the Centre d'Immunologie de Marseille-Luminy (CIML), Inserm, CNRS et Aix-Marseille Université and King’s College London have found potential ‘magic bullet’ for treating tumours. This study is published in the Journal of Experimental Medicine...…
A thesis prize from Aix-Marseille University 2018 is awarded to Noushine MOSSADEGH-KELLER, PhD at the CIML, in recognition of the excellence of her research work.
This prize will be awarded to her on Wednesday, November 13, 2019 at the 2018 thesis prize ceremony in Aix-Marseille University.
A new ERC funding "Proof of Concept (PoC) Grant" awarded to Eric VIVIER, DVM, PhD, Professeur en immunologie, Hôpital de la Timone, Assistance-Publique des Hôpitaux de Marseille, Centre d’Immunologie de Marseille…
Magali IRLA, PhD, at the CIML has been nominated as a laureate of the National Academy of Medicine for the 2019 Prize of the Société des Eaux Minérales d'Evian-les-Bains which aims to encourage scientific research. This prize is awarded for her work entitled: "At the heart of the establishment of immune tolerance: regulation of…
Michel PIERRES, a world-renowned physician and immunologist, died on June 14, 2019
One of the first team leaders of the CIML, Michel Pierres was director of the centre from 1991 to 1995. His work on the characterization of molecules associated with T lymphocyte activation using monoclonal antibodies helped to position the…
Le rapport d'activité Inserm 2018 vient de paraitre
Parmi les avancées scientifiques de l'année 2018, en page 9, un article sur les travaux de l'équipe d'Eric VIVIER du Centre d'Immunologie de Marseille-Luminy : Un nouvel anticorps efficace contre le cancer de la tête et du cou...…
A study by the Bernard Malissen (CIML CNRS, Inserm, AMU Marseille), M. Gstaiger (IMSB) and R. Aebersold (IMSB) groups which appeared in Cell Reports, identifies using proteomics and mouse models molecular mechanisms that might account for some of the failures observed during immunotherapy...…
